VivoSeq
Other

Mood

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Mood is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed9 · 75%
Not yet recruiting1 · 8%
Unknown status1 · 8%
Terminated1 · 8%

Trial Activity

12 trials

Sustained Mood Improvement With Laughing Gas Exposure
Not yet recruiting·WWomen's College Hospital·Phase 3·NCT07262008·120 enrolled
Microdosing Psychedelics to Improve Mood
Completed··Phase 2·NCT05259943·39 enrolled
Mood Effects of Serotonin Agonists
Completed·UUniversity of Chicago·Phase 1·NCT03790358·80 enrolled
Mood Effects of Serotonin Agonists Extended
Completed·UUniversity of Chicago·Phase 1·NCT03934710·56 enrolled
Does Salt Intake Improve Mood
Unknown status·SSwansea University·N/A·NCT03467568·120 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)